EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous 
Evolva announces Chief Financial Officer to depart 
02-March-2021 / 07:00 CET/CEST 
Release of an ad hoc announcement pursuant to Art. 53 KR 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Reinach, March 2, 2021 - Evolva announced today that André Pennartz, CFO of Evolva, is leaving the company for personal 
reasons with immediate effect. 
Oliver Walker, CEO of Evolva, said:«I'd like to thank André Pennartz for his contributions and wish him the best for 
his future.» 
Oliver Walker will take on the role of CFO ad interim until a successor is appointed. 
About Evolva 
Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on 
nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's 
employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing 
and sensory enjoyment. Find out more at www.evolva.com. 
For Evolva multi media content, please visit: https://evolva.com/multimedia-library/. 
Contact 
Barbara Duci 
Head of Investor and Corporate Relations 
+41 61 485 2003 
+41 79 739 2636 
barbarad@evolva.com 
=---------------------------------------------------------------------------------------------------------------------- 
End of ad hoc announcement 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Evolva Holding SA 
              Duggingerstrasse 23 
              4153 Reinach 
              Switzerland 
Phone:        +41 61 485 20 00 
Internet:     www.evolva.com 
ISIN:         CH0021218067 
Valor:        2121806 
Listed:       SIX Swiss Exchange 
EQS News ID:  1172252 
 
End of Announcement EQS Group News Service 
=------------

1172252 02-March-2021 CET/CEST

(END) Dow Jones Newswires

March 02, 2021 01:02 ET (06:02 GMT)